Evidence map›Paper›PMID 37272463›Full record

ReviewCurrent molecular medicine2024

Genetic Aspects of Glaucoma: An Updated Review.

Oscar Francisco Chacon-Camacho, Rocio Arce-Gonzalez, Fernanda Sanchez-de la Rosa, Andrés Urióstegui-Rojas, María Enriqueta Hofmann-Blancas, Felipe Mata-Flores, Juan Carlos Zenteno

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Oscar Francisco Chacon-CamachoDepartment of Genetics, Institute of Ophthalmology "Conde de Valenciana", Mexico City, Mexico.
Rocio Arce-GonzalezDepartment of Genetics, Institute of Ophthalmology "Conde de Valenciana", Mexico City, Mexico.
Fernanda Sanchez-de la RosaDepartment of Genetics, Institute of Ophthalmology "Conde de Valenciana'.
Andrés Urióstegui-RojasDepartment of Integral Ophthalmology, Institute of Ophthalmology "Conde de Valenciana", Mexico City, Mexico.
María Enriqueta Hofmann-BlancasDepartment of Glaucoma, Institute of Ophthalmology "Conde de Valenciana".
Felipe Mata-FloresDepartment of Glaucoma, Institute of Ophthalmology "Conde de Valenciana", Mexico City, Mexico.
Juan Carlos ZentenoDepartment of Genetics, Institute of Ophthalmology "Conde de Valenciana", Mexico City, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glaucoma is a group of diverse diseases characterized by cupping of the optic nerve head due to the loss of retinal ganglion cells. It is the most common cause of irreversible blindness throughout the world; therefore, its timely diagnosis and early detection through an ophthalmological examination are very important. We, herein, present the information on the epidemiology, pathophysiology, clinical diagnosis, and treatment of glaucoma. We also emphasize the investigations of the last decades that have allowed identifying numerous genes and susceptibility genetic factors. We have also described in detail the genes whose mutations cause or contribute to the development of the disease.

Indexed as

Genetic Predisposition to DiseaseGlaucomaHumansMutationRetinal Ganglion Cellsblindnesselevated intraocular pressure.Glaucomaglaucoma genesglaucoma geneticsmicroarraysmonogenic glaucomaNGS

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.